CCND1 and B-cell non-Hodgkin lymphoma: In their study, a model of tumor dormancy was used, in which a murine B cell lymphoma (BCL1) implanted in immunocompetent mice previously immunized with the BCL1-derived Ig to orchestrate an anti-Id immune response could be induced into a dormant state.